Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation
- 15 March 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 45 (6) , 838-845
- https://doi.org/10.1016/j.jacc.2004.11.051
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Estimating Survival for Cost-Effectiveness Analyses: A Case Study in AtherothrombosisValue in Health, 2004
- 889-3 Estimating life-years lost due to atherothrombotic events: Flexible survival functions for use in disease modelingJournal of the American College of Cardiology, 2004
- Cost and Cost-effectiveness of an Early Invasive vs Conservative Strategy for the Treatment of Unstable Angina and Non–ST-Segment Elevation Myocardial InfarctionJAMA, 2002
- A cardiovascular life historyPublished by Oxford University Press (OUP) ,2002
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment ElevationNew England Journal of Medicine, 2001
- Cost Effectiveness of Simvastatin Treatment to Lower Cholesterol Levels in Patients with Coronary Heart DiseaseNew England Journal of Medicine, 1997
- Adjusting Survival Curves for Confounders: A Review and a New MethodAmerican Journal of Epidemiology, 1996
- Cholesterol Lowering and the Use of Healthcare ResourcesCirculation, 1996
- Cost and health implications of cholesterol lowering.Circulation, 1992
- Adjusted survival curve estimation using covariatesJournal of Chronic Diseases, 1982